PT Biomedical Indonesia (BMTI) is a company engaged in the provision of laboratory animals and Contract Research Organization (CRO) services that support research, development, and testing activities in the fields of biomedicine, pharmaceuticals, healthcare, and biotechnology. BMTI provides a wide range of healthy, standardized, and traceable laboratory animals, maintained by applying the principles of animal welfare and 3R (Replacement, Reduction, Refinement), and in accordance with national and international ethical and regulatory standards. All maintenance, breeding, and distribution processes are carried out under the supervision of competent professionals in the field of laboratory animals.

As a CRO, PT. BMTI provides in vivo research and preclinical research support services, including study design, test execution, data collection and analysis, as well as the preparation of scientific reports. CRO services are conducted in accordance with laboratory quality standards and animal ethics committee regulations. With the support of experienced human resources, adequate facilities, and a sustainable quality management system, PT. BMTI is committed to becoming a strategic and trusted partner for the pharmaceutical industry, research institutions, academia, and healthcare product development organizations in generating research data that are accurate, valid, and scientifically and ethically accountable.